Page last updated: 2024-10-24

cefuroxime and Respiratory Syncytial Virus Infections

cefuroxime has been researched along with Respiratory Syncytial Virus Infections in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Respiratory Syncytial Virus Infections: Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peltola, V1
Svedström, E1
Waris, M1
Heikkinen, T1
Ruuskanen, O1

Other Studies

1 other study available for cefuroxime and Respiratory Syncytial Virus Infections

ArticleYear
Pulmonary abscess of viral-bacterial etiology in a neonate.
    European journal of pediatrics, 2007, Volume: 166, Issue:12

    Topics: Anti-Infective Agents; Cefuroxime; Cephalexin; Escherichia coli Infections; Female; Humans; Infant,

2007